ORJ-001 achieved therapeutic exposure and was well tolerated in Phase 1 study, supporting company’s plans to initiate Phase 2 clinical trial in IPF patients ...
Governing AI Agents and Non‑Human Identities in Oracle, SAP, and Business‑Critical SaaS A Federated Control Plane for Human and Non‑Human Identities in SOX/ITGC‑Governed ERP Environments Executive ...
Company announces $30 million Series A financing and founding leadership team with expertise in pulmonary drug innovation and track record advancing novel therapies to patients ORJ-001, set to begin a ...
First-in-human healthy volunteers trial showed SYX-5219 was safe and well toleratedSystemic immunomodulation of type 2 ...
Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...
Phase 3 ARISE trial of solengepras, a potential first-in-class non-dopaminergic therapy, is fully enrolled and topline data ...
The first quarter 2026 financial results and business update will be discussed during a conference call and webcast presentation today at 2:30 PM CET/8:30 AM ET. A webcast of the live call may be ...
The USS Gerald R. Ford, the world largest aircraft carrier, returned home to Virginia on Saturday after an 11-month ...
Pieter Martens, MD, PhD (Hospital Oost-Limburg, Genk, Belgium), who made the “pro” case on behalf of IV iron, pointed out ...
Completed successful FDA End-of-Phase 2 meeting, reaching alignment on the study parameters of RESTORE, a registrational study of NVG-291 in chronic tetraplegia, with site activation underway and stud ...
The Nationals are better than their 19-22 record would indicate through the first quarter of the MLB season. The rebuilding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results